Armouring Effector Cells Against Oxidative Stress to Enhance Function & Persistence of T-Cell Based Therapies

• Present preclinical findings demonstrating how oxidative stress armouring can protect TILs and maintain their antitumour activity
• Discuss how enhancing TIL resilience to oxidative damage could improve durability and therapeutic outcomes in solid tumours

Speakers:

Ulrik Cordes

Chief Executive Officer

CBio